Nick Pizzie, C.P.A., M.B.A., serves as the Chief Financial Officer at Axsome Therapeutics Inc., a biopharmaceutical company focused on developing novel therapies for central nervous system disorders. With over two decades of experience in finance and accounting, Pizzie has become a pivotal figure in the company's growth and success. He holds a Master of Business Administration from Fordham University and is a Certified Public Accountant, which has equipped him with the necessary skills to navigate the complex financial landscape of the pharmaceutical industry. Before joining Axsome Therapeutics, Pizzie held various high-level financial positions at several notable companies. He served as the Vice President of Finance at Glenmark Pharmaceuticals, where he played a crucial role in the company's financial strategy and growth. Prior to that, he worked at Purdue Pharma, where he gained extensive experience in the pharmaceutical sector. His expertise in financial planning, analysis, and reporting has been instrumental in guiding Axsome Therapeutics through its various stages of development and expansion. As the Chief Financial Officer at Axsome Therapeutics, Pizzie is responsible for overseeing the company's financial operations, including budgeting, forecasting, and investor relations. Under his leadership, the company has successfully navigated the challenges of bringing new therapies to market, securing funding, and maintaining compliance with regulatory requirements. His strategic vision and financial acumen have been key factors in Axsome's ability to advance its pipeline of innovative treatments and achieve sustainable growth. Pizzie's contributions have not only strengthened the company's financial position but also enhanced its reputation within the industry.